| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.36 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |